# Hemab Therapeutics Holdings, Inc. (COAG) - Q2 2026 earnings

Reported May 21, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-23.98 | $-23.25 |

Earnings filing reader: [8-K 0001193125-26-233375](https://www.opencapital.sh/filings/0001193125-26-233375)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-233375.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/2114044/000119312526233375/0001193125-26-233375-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/2114044/000119312526344533/0001193125-26-344533-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/coag/earnings/q2-2026